Study | n | Infection | Blood loss | Health service use | Other outcomes | ||||
---|---|---|---|---|---|---|---|---|---|
Outcome | Result | Outcome | Result | Outcome | Result | Outcome | Result | ||
Cochrane review 15 | 1,006 | Endometritis (n = 784) (RR) | 1.22 (0.91–1.63) | Transfusion (n = 906) (RR) | 0.80 (0.34–1.92) | Operating time (Mean) | 43.8 v 47.5 min | Moderate or major deformity of | 0.19 (0.06–0.60) |
Extra haemostatic sutures (n = 906) (RR) | 0.93 (0.79–1.08) | scar on radiography (n = 100) (RR) | |||||||
>8% drop in haematocrit (n = 906) (RR) | 1.09 (0.86–1.38) | ||||||||
Heidenreich 17 | 125 | Post-operative fever | 4.8% v. 7.2% | Transfusion | 3.8% v. 3.2% | Scar thickness by US (8–10 days after surgery) | 0.72 v. 0.82 cm | ||
Sood 18 | 208 | Febrile morbidity (RR) | 0.50 (0.27–0.94) | Intraoperative blood loss (Mean) | 600 v. 629.6 ml | Operating time (Mean) Hospital stay (Mean) | 31.3 v. 33.1 min 6.67 v. 7.19 days | Pain (VAS Score) (Mean) | 2.91 v. 3.05 |
Endometritis (RR) | 0.44 (0.20–0.95) | Additional suture (RR) | 1.36 (0.85–2.17) | ||||||
Wound infection (RR) | 0.46 (0.15–1.45) |